Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00186992 · ClinicalTrials.gov registry record · Phase 2
Radiation Therapy to Treat Musculoskeletal Tumors
A Phase 2 study of Soft Tissue Sarcoma and Rhabdomyosarcoma, sponsored by St. Jude Children's Research Hospital.
- Active
- Registry status
- Phase 2
- Development phase
- 202
- Enrollment target
- 1
- Study location
NCT00186992: Active Phase 2 study of Soft Tissue Sarcoma and Rhabdomyosarcoma, sponsored by St. Jude Children's Research Hospital.
NCT00186992 is a Phase 2 study of Soft Tissue Sarcoma and Rhabdomyosarcoma that is active but no longer recruiting, run by St. Jude Children's Research Hospital. The registered enrollment target is 202 participants, above the 75-participant average among 55 other Soft Tissue Sarcoma trials with a reported enrollment target (169% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00186992, a Phase 2 study of Soft Tissue Sarcoma and Rhabdomyosarcoma, is active but no longer recruiting, sponsored by St. Jude Children's Research Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 202 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers at St. Jude Children's Research Hospital are looking for more effective ways to deliver radiation therapy to pediatric tumors of the bone and soft tissues. The goal of the study is to improve local control of musculoskeletal tumors with image-guided radiation therapy (IGRT) while minimizing radiation related side effects. IGRT uses computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET) images to precisely define tumor location and to carefully plan radiation treatment. This approach allows doctors to deliver highly conformal radiation therapy to the tumor while protecting nearby healthy normal tissues.
Primary Outcome
The cumulative incidence of local failures is used to report the control of local failures in patients with image guided radiation therapy as defined in this study for patients with primary musculoskeletal tumors (MST).
Conditions Studied
Interventions
- RADIATION image-guided radiotherapy
Study Locations (1)
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2003-01-10 |
| Est. Completion | 2029-10 |
| Phase | Phase 2 |
What the registry record for NCT00186992 still lists
NCT00186992 is an interventional study that assigns participants to a tested intervention. The registered 202 participants enrollment target is mid-sized for trials with a published cap, above the 75-participant average among 55 other Soft Tissue Sarcoma trials with a reported enrollment target (169% higher).
The record links to 4 conditions, with Soft Tissue Sarcoma appearing as the primary indexed condition, and to 1 intervention - of which image-guided radiotherapy is the first listed.
NCT00186992 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00186992 about?
NCT00186992 is a clinical study titled "Radiation Therapy to Treat Musculoskeletal Tumors". Researchers at St. Jude Children's Research Hospital are looking for more effective ways to deliver radiation therapy to pediatric tumors of the bone and soft tissues. The goal of the study is to improve local control of musculoskeletal tumors with image-guided radiation therapy (IGRT) while minimiz...
What is the current status of trial NCT00186992?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 202 participants. The study started on 2003-01-10. Estimated completion is 2029-10.
What conditions does trial NCT00186992 study?
This clinical trial studies the following conditions: Soft Tissue Sarcoma, Rhabdomyosarcoma, Sarcoma, Ewing's, Musculoskeletal Tumors.
What interventions are being tested in trial NCT00186992?
The interventions under investigation include: image-guided radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT00186992?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00186992 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Soft Tissue Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00186992's enrollment target sits among peer trials
202 7th of 55 higher than 49 of 55 other Soft Tissue Sarcoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Soft Tissue Sarcoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma
RECRUITING · Phase 2
-
Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma
RECRUITING · Phase 2
-
Hypofractionated vs Conventional Fractionated RT in Soft Tissue Sarcomas
RECRUITING · Phase 2
-
SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma
RECRUITING · Phase 2
-
5-Day Preoperative Radiation for Soft Tissue Sarcoma
RECRUITING · Phase 2
-
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05272254 · 202 participants · Phase 2
Povidone Iodine Efficacy Study
- NCT05701280 · 202 participants · NA
Pilot/Pivotal Study of DBS+Rehab After Stroke
- NCT05932589 · 202 participants
Neurophysiologic Biomarkers in Rett Syndrome
- NCT06014931 · 202 participants · NA
Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI